First Trust Advisors
TXG icon

First Trust Advisors’s 10x Genomics TXG Stock Holding History

First Trust Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
414,894
+402,135
+3,152% +$10.5M 0.01% 1017
2026
Q1 		$271K Buy
+12,759
New +$255K ﹤0.01% 2489
2025
Q1 		– Sell
-217,558
Closed -$3.12M – 2627
2024
Q4 		$3.12M Buy
217,558
+133,841
+160% +$2.11M ﹤0.01% 1620
2024
Q3 		$1.89M Buy
83,717
+73,624
+729% +$1.52M ﹤0.01% 1793
2024
Q2 		$196K Sell
10,093
-569,791
-98% -$14.9M ﹤0.01% 2255
2024
Q1 		$21.8M Buy
579,884
+565,532
+3,940% +$24.8M 0.02% 764
2023
Q4 		$803K Sell
14,352
-229,588
-94% -$9.99M ﹤0.01% 2032
2023
Q3 		$10.1M Sell
243,940
-26,929
-10% -$1.4M 0.01% 982
2023
Q2 		$15.1M Buy
270,869
+264,247
+3,990% +$14.3M 0.02% 875
2023
Q1 		$369K Buy
6,622
+362
+6% +$16.9K ﹤0.01% 2198
2022
Q4 		$228K Sell
6,260
-2,581
-29% -$84.4K ﹤0.01% 2354
2022
Q3 		$252K Sell
8,841
-1,463
-14% -$55.7K ﹤0.01% 2366
2022
Q2 		$466K Sell
10,304
-25,797
-71% -$1.34M ﹤0.01% 2219
2022
Q1 		$2.75M Sell
36,101
-75,566
-68% -$6.61M ﹤0.01% 1646
2021
Q4 		$16.6M Sell
111,667
-240,512
-68% -$36.8M 0.02% 904
2021
Q3 		$51.3M Buy
352,179
+37,268
+12% +$6.4M 0.06% 454
2021
Q2 		$61.7M Buy
314,911
+57,735
+22% +$10.4M 0.07% 397
2021
Q1 		$46.5M Sell
257,176
-58,418
-19% -$10.1M 0.06% 453
2020
Q4 		$44.7M Buy
315,594
+266,253
+540% +$38.6M 0.06% 443
2020
Q3 		$6.15M Buy
+49,341
New +$5.18M 0.01% 896

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Trust Advisors's TXG Position: Q2 2026 in Review

First Trust Advisors increased its 10x Genomics (TXG) stake by 3,152% in Q2 2026, buying an estimated $10.5M and bringing the position to 414,894 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #1017.

First Trust Advisors first reported a position in TXG in Q3 2020 and has held it in 20 quarters since. The position peaked at $61.7M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • First Trust Advisors held 414,894 shares of 10x Genomics worth $15.9M as of Q2 2026.
  • First Trust Advisors bought 402,135 10x Genomics shares in Q2 2026, an estimated $10.5M.
  • 10x Genomics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1017 holding.
  • First Trust Advisors first reported a position in 10x Genomics in Q3 2020 and has held it in 20 quarters since.
  • First Trust Advisors's 10x Genomics position peaked at $61.7M in Q2 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.